Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1904)
NICE advice (320)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 1071 to 1080 of 1904
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
TA455
12 July 2017
12 July 2017
Ustekinumab for moderately to severely active Crohn's disease after previous treatment
TA456
12 July 2017
12 July 2017
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners
DG3
25 January 2012
6 July 2017
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)
TA452
5 July 2017
5 July 2017
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)
TA453
5 July 2017
5 July 2017
Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA454
5 July 2017
5 July 2017
Air pollution: outdoor air quality and health
NG70
30 June 2017
30 June 2017
Etelcalcetide for treating secondary hyperparathyroidism
TA448
28 June 2017
28 June 2017
Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease
TA449
28 June 2017
28 June 2017
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia
TA450
28 June 2017
28 June 2017
Previous page
1
…
106
107
Current page
108
109
110
…
191
Page
108
of
191
Next page
Results per page
10
25
50
All
Back to top